The initial clinical investigation of tirzepatide shows unprecedented efficacy for glucose lowering and weight loss in T2DM as about 30% of patients receiving the 15 mg dose reached normoglycemia (HbA1C 95% purity at Eli Lilly and Company or obtained from Caslo
This guide compares both peptides side by side, examining their structures, receptor roles, potential benefits, common side effects, and support for specific study goals
Quality-Assured IngredientsManufactured by OstroVit, known for high-quality, science-backed supplements
Ultimately, the decision to continue or discontinue GLP-1 therapy should be individualized, considering treatment response, tolerability, patient preferences, cost, and overall health status